The Department of Health and Human Services will create a Foundry for American Biotechnology to produce technological solutions to address health security threats and enhance daily medical care, the agency announced today. The foundry will be located in Manchester, N.H., and managed in conjunction with the Advanced Regenerative Manufacturing Institute led by DEKA Research Corp., as part of a public-private partnership with HHS’ Office of the Assistant Secretary for Preparedness and Response. Its first project, a partnership with the Defense Advanced Research Projects Agency, will focus on maturing and validating small, automated devices that could go to disaster locations to make necessary medicines on site.

Related News Articles

Headline
AHA President and CEO Rick Pollack opened the 2024 AHA Leadership Summit in San Diego discussing the similarities of the U.S. Navy Seals to the hospital field…
Headline
The AHA July 19 expressed concerns to the Department of Labor about the Occupational Safety and Health Administration’s proposed emergency response rule. The…
Headline
A non-malicious global technology outage that began in the early morning of July 19 is continuing to affect many industries and is having varying effects on…
Headline
John Riggi, AHA’s national advisor for cybersecurity and risk, participated July 18 as the opening keynote speaker in the Information Security Media Group’s…
Headline
A joint advisory issued the week of July 8 by the Cybersecurity and Infrastructure Security Agency, National Security Agency, FBI and several international…
Headline
The AHA July 2 submitted comments to the Cybersecurity and Infrastructure Security Agency on its proposed rule establishing reporting requirements for…